12 Health Care Stocks Moving In Friday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Friday's after-market session, several healthcare stocks experienced significant movements. Alaunos Therapeutics (TCRT) led the gainers with a 20.9% increase, while Minerva Surgical (UTRS) headed the losers with a 13.1% decline. Other notable movers included Impel Pharmaceuticals (IMPL), I-MAB (IMAB), Genprex (GNPX), and Adaptimmune Therapeutics (ADAP) with gains, and Procaps Gr (PROC), Virpax Pharmaceuticals (VRPX), Asensus Surgical (ASXC), Intensity Therapeutics (INTS), and Forte Biosciences (FBRX) with losses.
December 15, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Adaptimmune Therapeutics' stock rose 6.22% to $0.48, with a market cap of $108.5 million.
ADAP's positive movement in the after-market could indicate a short-term upward trend in its stock price, reflecting investor confidence.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Genprex stock increased by 6.63% to $0.23, with a market cap of $13.3 million.
The after-market gain for GNPX could lead to a short-term positive price movement as investors may continue to trade positively based on the after-market session.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
I-MAB shares rose 7.19% to $1.49, with a market cap of $123.1 million.
I-MAB's stock price increase in the after-market session could suggest a short-term bullish trend due to investor optimism.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Impel Pharmaceuticals' shares increased by 11.98% to $0.27, with a market cap of $6.4 million.
The after-market rise for IMPL indicates a positive reaction from investors, potentially leading to a short-term positive trend in its stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Alaunos Therapeutics' stock rose 20.9% to $0.06, with a market cap of $13.2 million.
The significant after-market gain for TCRT suggests positive investor sentiment which could lead to a short-term upward price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Asensus Surgical shares declined by 9.68% to $0.28, with a market cap of $74.0 million.
ASXC's stock price decrease after-market may continue into the short term, reflecting the negative investor response.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Forte Biosciences shares declined by 8.11% to $0.69, with a market cap of $25.0 million.
FBRX's after-market decline may lead to further short-term losses in stock price, as the market reacts negatively.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Intensity Therapeutics shares fell 8.94% to $7.34, with a market cap of $100.6 million.
The negative after-market movement for INTS could suggest a short-term downward trend in its stock price due to investor pessimism.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Procaps Gr stock fell 12.34% to $2.7, with a market cap of $304.6 million.
PROC's after-market decline may lead to a short-term negative trend in its stock price due to the bearish investor reaction.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Minerva Surgical's stock declined by 13.1% to $2.45, with a market cap of $21.7 million.
The significant after-market drop for UTRS could suggest a negative investor sentiment, potentially leading to a short-term downward price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Virpax Pharmaceuticals shares fell 9.99% to $0.35, with a market cap of $4.1 million.
The after-market drop in VRPX's stock price could indicate a short-term bearish trend, as investor sentiment appears negative.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100